Product complaint # (b)(4).Additional information: component code: g07002 - device not returned.As no contact information has been provided, no follow up can or will be performed at this time.If further details are received at a later date a supplemental medwatch will be sent.This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.The single complaint was reported with multiple events.There are no additional details regarding the additional events.Citation: british society for cutaneous allergy, vol.185, pages 1-1 (uk) journal article attached this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
It was reported via journal article: title: two cases of follicular allergic contact dermatitis following the use of cyanoacrylate surgical glue a case of a 42-year-old woman who developed a pruritic follicular rash with associated discharge at the portal sites 3 days after her laparoscopic gastric band removal the rash was present around the portal sites, extending more widely around the sites where dermabond (ethicon) surgical glue (2- octylcyanoacrylate) had been used.She was treated with flucloxacillin, with little benefit.She had a history of previous laparoscopic surgeries for cholecystectomy and appendectomy, with primary closures of the portal sites with sutures only.Examination revealed erythematous follicular papules adjacent to the scar.Patch testing to the bsca standard and acrylate series showed positive reactions to dermabond.In conclusion, this also highlights the importance of testing to the patient's own products as there is currently only one cyanoacrylate, ethyl cyanoacrylate.
|